Cancer Supportive Care Drugs Market

Cancer Supportive Care Drugs Market by Drug Class (G-CSFS, ESAS, Antiemetics, Bisphosphonates, Opioids, Nsaids), Cancer Type (Breast Cancer, Lung Cancer, Melanoma, Prostate Cancer, Other Cancers) - Global Forecast to 2023

Report Code: UC 1990 Feb, 2019, by marketsandmarkets.com

Cancer supportive care also known as palliative care is focused on relieving patients from side effects of cancer therapies. In cancer palliative care, supportive drugs are used to lessen the side effects of cancer treatments. In many cases cancer treatments need to be stopped or doses need to lowered due various reasons such as low blood cell counts. In such cases, cancer supportive drugs such as CSFs enable patients to continue with cancer treatments as well as in other cases, it also allows higher doses of cancer therapies. Cancer being one of the leading causes of death worldwide, there has been increasing focus on cancer treatments. Many cancer treatments comes with various side effects such as fatigue, pain, fertility problems, depression, heartburn, sexual problems, bone diseases and other side effects. With such side effects, there is preference to use supportive care drugs during cancer treatments. Such factors are expected to drive the cancer supportive care drugs market. However, there are some side effects associated with cancer supportive care drugs which may hinder the market growth.

The cancer supportive care drugs market is segmented based on drug class, cancer type, and region. the cancer supportive care drugs by drug class include granulocyte-colony stimulating factors (g-csfs), erythropoietin-stimulating agents (esas), antiemetics, bisphosphonates, opioids, nonsteroidal anti-inflammatory drugs (nsaids), others.

North America is expected to dominate the market in 2018, with the US accounting for a major share. However, Asia Pacific is expected to grow at the highest CAGR during the forecast period, due to the factors such as rising incidence of cancer, and expansions of major pharmaceutical companies in emerging Asian economies.

Table of Contents

1 Introduction
    1.1 Objectives of the Study
    1.2 Market Definition
           1.2.1 Markets Covered
           1.2.2 Years Considered for the Study
    1.3 Currency
    1.4 Limitations
    1.5 Stakeholders

2 Research Methodology

3 Executive Summary

4 Premium Insights

5 Market Overview
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Drivers
           5.2.2 Restraints
           5.2.3 Opportunities
           5.2.4 Challenges

6 Cancer Supportive Care Drugs Market, By Drug Class
    6.1 Granulocyte-Colony Stimulating Factors (G-CSFS)
    6.2 Erythropoietin-Stimulating Agents (ESAS)
    6.3 Antiemetics
    6.4 Bisphosphonates
    6.5 Opioids
    6.6 Nonsteroidal Anti-Inflammatory Drugs (NSAIDS)
    6.7 Other Drug Classes

7 Cancer Supportive Care Drugs Market, By Cancer Type
    7.1 Breast Cancer
    7.2 Lung Cancer
    7.3 Melanoma
    7.4 Prostate Cancer
    7.5 Other Cancers

8 Cancer Supportive Care Drugs Market, By Region
    8.1 Introduction
    8.2 North America
           8.2.1 US
           8.2.2 Canada
    8.3 Europe 
    8.4 Asia Pacific
    8.5 RoW

9 Competitive Landscape
    9.1 Market Overview
    9.2 Market Ranking Analysis, 2018
    9.3 Competitive Situation and Trends
           9.3.1 Product Launches & Approval
           9.3.2 Acquisitions
           9.3.3 Agreements
           9.3.4 Other Developments

10 Company Profiles
(Business Overview, Recent Financials, Products Offered, Recent Developments, MnM View)*
     10.1 Amgen
     10.2 Johnson & Johnson
     10.3 Novartis
     10.4 Baxter International
     10.5 Fagron Group.
     10.6 Teva Pharmaceuticals Industries
     10.7 Hoffmann La- Roche 
     10.8 Apr Applied Pharma Science Research
     10.9 Acacia Pharma
     10.10 Kyowa Hakko Kirin

*Details on Business Overview, Recent Financials, Recent Developments, Key Relationships Might Not Be Captured in Case of Unlisted Companies.

11 Appendix


Request for detailed methodology, assumptions & how numbers were triangulated.

Please share your problem/objectives in greater details so that our analyst can verify if they can solve your problem(s).
  • Select all
  • News-Letters with latest Market insights
  • Information & discussion on the relevant new products and services
  • Information & discussion on Market insights and Market information
  • Information & discussion on our events and conferences
    • Select all
    • Email Phone Professional and social network (Linkedin, etc)
Report Code
UC 1990
Published ON
Feb, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Cancer Supportive Care Drugs Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved